Pricing Log in Create free account
Friday 6 November 2026 Export HCM’s income statement to Excel — free account

HUTCHMED (China) Limited Sponsored ADR

HCM Healthcare Drug Manufacturers Specialty & Generic

HUTCHMED (China) Limited Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $548.5 million, down 13.0% from fiscal 2024.

14.85 0.65 +4.58%
Market cap
$2.5B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
4/9
Altman Z
3.53
Beneish M
−1.20
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

HUTCHMED (China) Limited Sponsored ADR (HCM) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, HUTCHMED (China) Limited Sponsored ADR (HCM) trades at a EV/Sales of −0.1×. Over the past ten years it has ranged from −1.3× (June 2021) to 0.0× (December 2018); the current reading is higher than 17% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 2.9× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 −0.1× —
FY2024 −0.1× —
FY2023 −0.1× —
FY2022 −0.1× —
FY2021 −0.2× —
FY2020 −0.1× —
FY2019 −0.1× —
FY2018 −0.1× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period EV/Sales Change
Jun 2023 0.9× (61.09%)
Dec 2022 2.4× 7.29%
Jun 2022 2.2× 24.16%
Jun 2021 1.8× 725.68%
10 more quarters

Against its own ten years

Low −1.3× High 0.0×
Ten-year median −0.1×
Current reading's percentile 17

EV/Sales against peers

Company EV/Sales
HCM HUTCHMED (China) Limited Sponsored ADR −0.1×
RGC Regencell Bioscience Holdings Limited compare n/m
PRGO Perrigo Company plc compare 1.2×
ANIP ANI Pharmaceuticals, Inc. compare 1.6×
TRLV Trulieve Cannabis Corp. compare 2.0×
BCRX BioCryst Pharmaceuticals, Inc. compare 2.5×
PBH Prestige Consumer Healthcare Inc. compare 3.5×
XERS Xeris Biopharma Holdings, Inc. compare 6.7×
ALVO Alvotech compare 8.6×
Drug Manufacturers Specialty & Generic industry median 2.9×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on HCM